Worried about your symptoms?
Start the Dehydration test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Dry mouth
Cottonmouth
Fatigue
Dizziness
Heat exhaustion
Malaise
Sinus headache
Dark urine
Parched
Strong smelling urine
Loss of appetite
Extreme tiredness
Not seeing your symptoms? No worries!
Dehydration happens when you lose more fluid than you consume, leaving your body without enough water. Common causes include inadequate intake, diarrhea, vomiting, and fever. Dehydration can also cause serious complications like seizures, urinary and kidney problems.
Your doctor may ask these questions to check for this disease:
To prevent dehydration, drink plenty of fluids and eat foods with high water content, such as fruits. In severe cases, your doctor may provide intravenous fluids if oral rehydration isn't enough.
Reviewed By:
Unnati Patel, MD, MSc (Family Medicine)
Dr.Patel serves as Center Medical Director and a Primary Care Physician at Oak Street Health in Arizona. She graduated from the Zhejiang University School of Medicine prior to working in clinical research focused on preventive medicine at the University of Illinois and the University of Nevada. Dr. Patel earned her MSc in Global Health from Georgetown University, during which she worked with the WHO in Sierra Leone and Save the Children in Washington, D.C. She went on to complete her Family Medicine residency in Chicago at Norwegian American Hospital before completing a fellowship in Leadership in Value-based Care in conjunction with the Northwestern University Kellogg School of Management, where she earned her MBA. Dr. Patel’s interests include health tech and teaching medical students and she currently serves as Clinical Associate Professor at the University of Arizona School of Medicine.
Yoshinori Abe, MD (Internal Medicine)
Dr. Abe graduated from The University of Tokyo School of Medicine in 2015. He completed his residency at the Tokyo Metropolitan Health and Longevity Medical Center. He co-founded Ubie, Inc. in May 2017, where he currently serves as CEO & product owner at Ubie. Since December 2019, he has been a member of the Special Committee for Activation of Research in Emergency AI of the Japanese Association for Acute Medicine. | | Dr. Abe has been elected in the 2020 Forbes 30 Under 30 Asia Healthcare & Science category.
Content updated on Dec 13, 2024
Following the Medical Content Editorial Policy
Was this page helpful?
We would love to help them too.
With a free 3-min Dehydration quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms

Our AI

Your report

Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
See full list
Q.
Always Thirsty? 5 Health Causes for Women 30-45 & Next Steps
A.
For women 30 to 45 who feel thirsty all the time, the leading causes are dehydration, blood sugar changes including prediabetes or diabetes, hormonal shifts like perimenopause, pregnancy, or thyroid issues, medication side effects, and less commonly kidney or electrolyte problems. There are several factors to consider. See below for key signs to watch, practical hydration and diet tips, when to get simple blood and urine tests, how to review medications safely, and urgent red flags so you can choose the right next steps.
References:
* Rhee, E. J. "Pathophysiology and Treatment of Type 2 Diabetes Mellitus." *Journal of Clinical Endocrinology & Metabolism*, vol. 106, no. 3, 2021, pp. 817–826. pubmed.ncbi.nlm.nih.gov/33301540/
* Verbalis, J. G. "Diabetes Insipidus: A Clinical Review." *The New England Journal of Medicine*, vol. 384, no. 2, Jan. 2021, pp. 175-188. pubmed.ncbi.nlm.nih.gov/33430127/
* Mavragani, C. P., & Moutsopoulos, H. M. "Sjögren Syndrome: An Update on Pathogenesis, Clinical Manifestations, and Treatment." *Journal of Clinical Medicine*, vol. 12, no. 1, Dec. 2022, 185. pubmed.ncbi.nlm.nih.gov/36615024/
* Shoback, D. "Hypercalcemia: pathophysiology, diagnosis, and management." *Journal of Clinical Endocrinology & Metabolism*, vol. 106, no. 3, 2021, pp. 859–871. pubmed.ncbi.nlm.nih.gov/33301549/
* Goldman, G. S., & Verbalis, J. G. "Psychogenic Polydipsia: A Comprehensive Review." *Journal of Clinical Psychiatry*, vol. 84, no. 1, 2023, 22r14402. pubmed.ncbi.nlm.nih.gov/36723226/
Q.
Is Liquid IV Safe for Seniors? What Women Over 65 Must Know
A.
Liquid IV can be safe for some women over 65 when used occasionally, but there are several factors to consider: its sodium, sugar, and potassium may pose risks if you have high blood pressure, heart or kidney disease, diabetes, take certain medications, or if it is overused. For who should avoid it, safer everyday hydration options, tips for safer use, dehydration signs, and when to consult your clinician, see the complete answer below to guide your next steps.
References:
* Weinberg AD, Carbonell B, Jibani MM. Hydration and Older Adults: An Evidence-Based Approach. J Am Geriatr Soc. 2019 Aug;67(8):1569-1577. doi: 10.1111/jgs.15938. Epub 2019 May 14. PMID: 31087403.
* Palevsky PM, Nadkarni GN, Naumova E, et al. Fluid and electrolyte disorders in the elderly. Semin Nephrol. 2019 Mar;39(2):162-177. doi: 10.1016/j.semnephrol.2019.01.006. Epub 2019 Feb 16. PMID: 30935515.
* Sterns RH, Nigwekar SU. Hypernatremia in older adults: causes, consequences, and approaches to management. J Am Geriatr Soc. 2019 Aug;67(8):1588-1596. doi: 10.1111/jgs.15934. Epub 2019 May 14. PMID: 31087405.
* Freedman S, Finkelstein J, Mahant S. Comparison of commercial oral rehydration solutions with WHO oral rehydration solution in patients with acute gastroenteritis. J Pediatr. 2020 Jan;216:214-219. doi: 10.1016/j.jpeds.2019.09.020. Epub 2019 Nov 13. PMID: 31732297.
* Kinouchi K, Ohnishi S, Yano Y, et al. Association between polypharmacy and hypernatremia in older adults. Geriatr Gerontol Int. 2022 Jun;22(6):531-536. doi: 10.1111/ggi.14371. Epub 2022 Mar 22. PMID: 35318721.
Q.
Hydration for Seniors: Using Liquid IV to Prevent Fatigue
A.
Liquid IV can help some seniors reduce fatigue from mild dehydration by improving fluid absorption, though plain water should remain the daily hydration foundation. There are several factors to consider, including sodium and sugar content and conditions like high blood pressure, heart or kidney disease, and diabetes, and it should not replace medical care for severe dehydration or ongoing unexplained fatigue. See below to understand more.
References:
* Ganio MS, Johnson EC, Casa DJ, Maresh CM, Armstrong LE. Effect of hydration on fatigue and cognition in older adults: A systematic review. Br J Nutr. 2020 Jan;123(1):3-18. PMID: 31893529.
* Hooper L, Bunn D, Abdelhamid A, Gill P, Jennings A, Maas K, Campbell JL, Chassagne P, Crome P, de Vries OJ, Fleetcroft R, Forster A, Handoll H, Hayes MG, Hendry J, Hudson N, Jabbour K, Ladher K, McMurdo ME, Myint PK, Musson R, Narayanasamy M, Potter JF, Stott DJ, Thorpe GC, Wells G, While A. Effectiveness of oral rehydration solutions for preventing dehydration in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2019 Apr;67(4):655-667. PMID: 30675765.
* Mentes JC, Culp K, Maas ML, Rantz M. Prevalence of dehydration in community-dwelling older adults: A systematic review. J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):908-914. PMID: 27170146.
* Grandjean AC. Oral rehydration solution in the prevention and treatment of dehydration in older adults. Curr Opin Clin Nutr Metab Care. 2018 Mar;21(2):142-146. PMID: 29342084.
* Warren JL, Smith DL, Fox MT, Hollenbeak CS. Dehydration and older people: a systematic review of barriers and facilitators to adequate fluid intake. BMC Public Health. 2016 Apr 13;16:307. PMID: 27075775.
Q.
Liquid IV for Women: Is Targeted Hydration Worth It?
A.
Liquid IV can help some women rehydrate faster in specific situations like intense or prolonged exercise, heavy sweating, travel, or mild dehydration from illness; for everyday needs, plain water and regular meals are usually sufficient. There are several factors to consider, including its added sugar and sodium and precautions if you are pregnant, breastfeeding, or have diabetes, heart problems, or kidney disease; see below for when it is worth using, how to use it wisely, warning signs that need medical care, and other options that could change your next steps.
References:
* Wingo, J. E., et al. "Fluid and electrolyte balance in female athletes." J Sports Sci Med. 2005 Dec 1;4(4):325-335. PMCID: PMC3806173.
* Picard, M., et al. "Impact of water intake on maternal health and pregnancy outcomes: a systematic review." Nutr Rev. 2021 Mar 10;79(4):399-410. doi: 10.1093/nutrit/nuaa077. PMID: 32906371.
* Atherly, D. E., & Cynamon, H. A. "Oral rehydration solutions: A critical review." J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):214-23. doi: 10.1097/00005176-200203000-00003. PMID: 11953775.
* Lozowski, V., et al. "The impact of menstrual cycle on hydration status in eumenorrheic women." J Sci Med Sport. 2021 Sep;24(9):941-946. doi: 10.1016/j.jsams.2021.03.011. Epub 2021 Mar 25. PMID: 33863673.
* Kenney, E. L., et al. "Water intake and hydration status in a representative sample of US adults: the National Health and Nutrition Examination Survey (NHANES) 2009-2012." Am J Clin Nutr. 2017 Jul;106(1):162-171. doi: 10.3945/ajcn.116.149171. Epub 2017 May 17. PMID: 28515082.
Q.
Farxiga 10 mg: What It’s For, What to Expect, and When to Call Your Doctor
A.
Farxiga 10 mg is an SGLT2 inhibitor taken once daily to help control type 2 diabetes and to reduce hospitalizations and protect kidneys in heart failure and chronic kidney disease, even without diabetes; there are several factors to consider, so see below for who should avoid it and how to use it safely. You may notice more urination, thirst, and mild dizziness, while urgent care is needed for signs of ketoacidosis, serious infection, allergic reaction, little or no urination, or fainting; important red flags, sick-day rules, and next steps for your situation are detailed below.
References:
Scott LJ. Dapagliflozin: A Review in Type 2 Diabetes, Heart Failure with Reduced Ejection Fraction and Chronic Kidney Disease. Drugs. 2021 Jul;81(10):1199-1210. doi: 10.1007/s40265-021-01540-3. PMID: 34185123.
https://pubmed.ncbi.nlm.nih.gov/34185123/
McMurray JJV, Solomon SD, Inzucchi SC, Køber L, Kosiborod MN, Martinez JND, O'Meara MF, Rodgaard J, Sha K, Choudhry NK, Cunningham J, Ejvinsson D, Häggström E, Lam CSP, Goh TH, Petersson M, Wessman P, Langkilde AM; DAPA-HF Trial Committee and Investigators. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 15. PMID: 31532729.
https://pubmed.ncbi.nlm.nih.gov/31532729/
Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene TM, Hou FF, Mann JFE, McMurray JJV, Wright EM, Wong MG, Rossing P, Sjöström CD, Toto H, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24. PMID: 32970396.
https://pubmed.ncbi.nlm.nih.gov/32970396/
Wiviott SD, Raz I, Bonaca MS, Mosenzon O, Kato ET, Cahn AV, Silverman DA, Zelniker CE, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Thuren T, Cordero-Monte M, Hirshberg B, Frederich R, Dahmen M, Salsali A, Scirica BM, Braunwald E; DECLARE–TIMI 58 Investigators. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10. PMID: 30415602.
https://pubmed.ncbi.nlm.nih.gov/30415602/
Li J, Zhang D, Zhao H, Li H, Chen W. Safety and Tolerability of Dapagliflozin: A Systematic Review and Meta-Analysis of Clinical Trials. Cardiovasc Diabetol. 2021 Mar 18;20(1):64. doi: 10.1186/s12933-021-01258-3. PMID: 33736569; PMCID: PMC7974441.
Q.
On Farxiga 10 mg and Feeling “Off”? These 5 Side Effects Explain a Lot
A.
There are several factors to consider: feeling “off” on Farxiga 10 mg is most often explained by five effects of how the drug works, namely dehydration, low blood pressure on standing, urinary or genital infections, temporary changes in kidney function, and the rare but serious euglycemic diabetic ketoacidosis. Most are manageable with better hydration, slow position changes, monitoring, and prompt treatment of infections, but seek urgent care for severe dizziness, confusion, vomiting, breathing changes, or signs of infection, and do not stop the medication without medical guidance. Key warning signs, practical fixes, and when to call your clinician are explained in detail below.
References:
* Wang SS, Jiang X, Feng J. Safety and Tolerability of Dapagliflozin in Patients With Type 2 Diabetes Mellitus. Adv Ther. 2021 Apr;38(4):1753-1772. doi: 10.1007/s12325-021-01646-6. Epub 2021 Feb 24. PMID: 33629239; PMCID: PMC8004513.
* Wang H, Liu W, Yu X, Shi D, Li M. Effects of dapagliflozin on body composition, metabolic parameters, and adverse events in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2020 Jan;36(1):e3215. doi: 10.1002/dmrr.3215. Epub 2019 Oct 17. PMID: 31621254.
* Wang T, Gou S, Liang C, Wang H. Efficacy and safety of dapagliflozin in patients with type 2 diabetes and hypertension: A meta-analysis. Hypertens Res. 2019 Dec;42(12):1915-1926. doi: 10.1038/s41440-019-0309-9. Epub 2019 Aug 8. PMID: 31391515.
* Liu X, Zhang N, Wang Y, Zhang X, Li Y. Safety of Dapagliflozin in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Clinical Trials. J Clin Endocrinol Metab. 2016 Jun;101(6):2536-47. doi: 10.1210/jc.2016-1070. Epub 2016 Mar 29. PMID: 27031758.
* Kazi M, Jameel M, Al-Sabah S, Abdul S. Dapagliflozin for type 2 diabetes mellitus: an overview of the clinical evidence. Expert Rev Clin Pharmacol. 2014 Mar;7(2):121-34. doi: 10.1586/17512433.2014.887625. Epub 2014 Feb 6. PMID: 24502572.
Q.
Over 65? Farxiga Benefits vs Risks (Dehydration, UTIs, Dizziness)
A.
Farxiga can meaningfully help older adults by improving blood sugar with low hypoglycemia risk, reducing heart failure hospitalizations, and slowing kidney disease, but it can also increase dehydration, UTIs, and dizziness from lower blood pressure. There are several factors to consider; see below for details that could change your next steps. Staying well hydrated, reporting symptoms early, and reviewing other medications can reduce risks, especially if you use diuretics, have recurrent UTIs, fall risk, or advanced kidney disease. For personalized watch‑outs, red flags, and when to call your doctor, see the complete answer below.
References:
* Li D, Li H, Li S, Lin H, Jia W, Wang Z, Gu R. Dapagliflozin in elderly patients with type 2 diabetes: a systematic review and meta-analysis. J Diabetes Complications. 2019 May;33(5):372-381. doi: 10.1016/j.jdiacomp.2019.01.011. Epub 2019 Jan 21. PMID: 30678683.
* Alatawi Y, Alnami F, Alenzi F, Alenzi A, Alsogair M. Safety of SGLT2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus: A Narrative Review. Cureus. 2022 Oct 11;14(10):e30198. doi: 10.7759/cureus.30198. PMID: 36364132; PMCID: PMC9642699.
* Tella SH, Chung S, Gupte R, Vella A, Zaccardi F. Adverse events of SGLT2 inhibitors in older adults with type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab. 2020 Aug;22(8):1292-1304. doi: 10.1111/dom.14039. Epub 2020 May 19. PMID: 32415664.
* Cho NH, Vella A, Cho YK, Pan C, Han P, Li Y, Rhee EJ, Tan H, Yang W. Real-world effectiveness and safety of dapagliflozin in older patients with type 2 diabetes mellitus from the Asia-Pacific region: Results from the Asia-Pacific Diabetes and Cardiovascular (ADVICE) Registry. J Diabetes Investig. 2021 Jul;12(7):1233-1243. doi: 10.1111/jdi.13508. Epub 2021 Mar 22. PMID: 33918076; PMCID: PMC8255953.
* Mascolo A, Sessa M, Faillace P, Vitale C, Capuano A. Cardiorenal Benefits of SGLT2 Inhibitors in the Elderly: A Narrative Review. J Cardiovasc Dev Dis. 2022 May 19;9(5):165. doi: 10.3390/jcdd9050165. PMID: 35626998; PMCID: PMC9144490.
Q.
Women on Farxiga 10 mg: How to Lower Your UTI/Yeast Infection Risk
A.
Farxiga 10 mg can raise the chance of UTIs and vaginal yeast infections, with yeast infections more common, because it increases sugar in urine. Lower your risk with steady hydration and not holding urine, gentle fragrance free hygiene, keeping the area dry with breathable cotton underwear, tight glucose control, and cautious antibiotic use; know early symptoms, when to seek urgent care, and do not stop Farxiga without medical advice. There are several factors to consider and options if infections recur; see below to understand more.
References:
* Cai Z, Chen M, Liu Y, Li C, He J, Ma Z. Managing Urogenital Mycotic Infections in Patients Treated with SGLT2 Inhibitors: A Narrative Review. Front Endocrinol (Lausanne). 2022 Mar 3;13:825595. doi: 10.3389/fendo.2022.825595. eCollection 2022. PMID: 35308960; PMCID: PMC8929944.
* Mendes D, Alves C, da Silva-Maia P, Ruas V, Roque F, Figueiras A, Paredes S. SGLT2 inhibitors and genital infections: an updated narrative review. Expert Opin Drug Saf. 2023 Feb;22(2):167-179. doi: 10.1080/14740338.2023.2173199. Epub 2023 Feb 8. PMID: 36749117.
* Raz I, Nyirjesy P, Rosenberg E, Liu M, Hirshberg B, Johnson JR, Ptaszynska A. A practical guide to the prevention and management of urogenital infections in patients taking SGLT2 inhibitors. Diabetologia. 2019 Jul;62(7):1131-1141. doi: 10.1007/s00125-019-4860-9. Epub 2019 Apr 12. PMID: 30976822.
* Nyirjesy P, Draghici A. Urogenital Infections Associated With SGLT2 Inhibitors. Curr Diab Rep. 2017 Jul;17(7):49. doi: 10.1007/s11892-017-0873-1. Review. PMID: 28620857.
* Yang Z, Zhang Y, Wen J, Yan X. Risk of Genital and Urinary Tract Infections in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Ther. 2018 Jun;9(3):1021-1031. doi: 10.1007/s13300-018-0402-2. Epub 2018 Mar 15. PMID: 29546685; PMCID: PMC6014798.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

“World’s Best Digital
Health Companies”
Newsweek 2024

“Best With AI”
Google Play Best of 2023

“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1Miller HJ. Dehydration in the Older Adult. J Gerontol Nurs. 2015 Sep 1;41(9):8-13. doi: 10.3928/00989134-20150814-02. PMID: 26375144.
https://journals.healio.com/doi/10.3928/00989134-20150814-02Thomas DR, Cote TR, Lawhorne L, Levenson SA, Rubenstein LZ, Smith DA, Stefanacci RG, Tangalos EG, Morley JE; Dehydration Council. Understanding clinical dehydration and its treatment. J Am Med Dir Assoc. 2008 Jun;9(5):292-301. doi: 10.1016/j.jamda.2008.03.006. PMID: 18519109.
https://www.jamda.com/article/S1525-8610(08)00107-2/fulltextMaughan RJ, Shirreffs SM. Dehydration and rehydration in competative sport. Scand J Med Sci Sports. 2010 Oct;20 Suppl 3:40-7. doi: 10.1111/j.1600-0838.2010.01207.x. PMID: 21029189.
https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0838.2010.01207.xSarin A, Thill A, Yaklin CW. Neonatal Hypernatremic Dehydration. Pediatr Ann. 2019 May 1;48(5):e197-e200. doi: 10.3928/19382359-20190424-01. PMID: 31067335.
https://journals.healio.com/doi/10.3928/19382359-20190424-01